Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Helicobacter pylori: therapeutic targets Louw JA; Marks INYale J Biol Med 1998[Mar]; 71 (2): 113-7Helicobacter pylori is now considered a major pathogen of the upper gastrointestinal tract. It is seen as an important cause of peptic ulceration not associated with NSAID use. It is also increasingly linked to other diseases of the GI tract, although the relationship between the organism and conditions such as gastric cancer, non-ulcer dyspepsia and gastroesophageal reflux disease is not as clear as is the case in peptic ulcer disease. This is probably because of a lack of well-performed, statistically powerful, prospective therapeutic trials that indicate that H. pylori eradication is of benefit in these diseases. The high infection rate without overt disease seen in many populations, especially from developing countries, probably contributes to this "credibility gap." While we have excellent therapeutic regimens available at this time, rational targeting requires that the objective evidence in favor of therapeutic intervention in upper GI disease, as well as the local H. pylori epidemiology, needs to be considered.|*Helicobacter pylori[MESH]|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use[MESH]|Dyspepsia/microbiology[MESH]|Gastritis/microbiology[MESH]|Gastroenteritis/*drug therapy/*microbiology[MESH]|Guidelines as Topic[MESH]|Helicobacter Infections/*drug therapy/microbiology[MESH]|Humans[MESH]|National Institutes of Health (U.S.)[MESH]|Peptic Ulcer/microbiology[MESH]|Proton Pump Inhibitors[MESH]|United States[MESH] |